SCHEMBL6869359

SCHEMBL6869359

CCCCCCCCCCCC(CC(=O)OC)C(=O)OCC

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
ZDHHC7 Q9NXF8 1/20 0.49
BIRC2 Q13490 5/20 0.48
CPB2 Q96IY4 2/20 0.47
CA2 P00918 2/20 0.47
CA1 P00915 1/20 0.47
USP2 O75604 1/20 0.44
LMNA P02545 1/20 0.44
MEN1 O00255 1/20 0.42
HPGD P15428 1/20 0.42
RECQL P46063 1/20 0.42
KMT2A Q03164 1/20 0.42
HSD17B10 Q99714 1/20 0.42
GPR84 Q9NQS5 4/20 0.40
ABCB1 P08183 1/20 0.39
POLB P06746 1/20 0.39
POLA1 P09884 1/20 0.39
GRIK1 P39086 1/20 0.39
GRIK2 Q13002 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6873375 1.00 ZDHHC7 (0.49) ZDHHC7BIRC2CPB2CA2CA1
SCHEMBL6868546 1.00 ZDHHC7 (0.49) ZDHHC7BIRC2CPB2CA2CA1
SCHEMBL6873204 1.00 ZDHHC7 (0.49) ZDHHC7BIRC2CPB2CA2CA1
SCHEMBL6863206 1.00 ZDHHC7 (0.49) ZDHHC7BIRC2CPB2CA2CA1
SCHEMBL6870914 1.00 ZDHHC7 (0.49) ZDHHC7BIRC2CPB2CA2CA1
SCHEMBL6871632 1.00 ZDHHC7 (0.49) ZDHHC7BIRC2CPB2CA2CA1
SCHEMBL6873866 1.00 ZDHHC7 (0.49) ZDHHC7BIRC2CPB2CA2CA1
SCHEMBL6863987 0.98 BIRC2 (0.49) ZDHHC7BIRC2CPB2CA2CA1
SCHEMBL6870428 0.93 CA2 (0.55) ZDHHC7BIRC2CPB2CA2CA1
SCHEMBL6870871 0.90 CPB2 (0.50) ZDHHC7BIRC2CPB2CA2CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1165633-B1 COMPONENTS AND CATALYSTS FOR THE POLYMERIZATION OF OLEFINS BASELL POLIOLEFINE SPA (IT) 2004-07-14 EP disclosed
US-6716939-B2 COMPRISING TITANIUM, MAGNESIUM, HALOGEN AND AN ELECTRON DONOR COMPOUND SELECTED FROM ESTERS OF SUBSTITUTED SUCCINIC ACIDS BASELL POLIOLEFINE ITALIA S.P.A. (IT) 2004-04-06 US disclosed
US-20020183575-A1 Components and catalysts for the polymerization of olefins BASELL POLIOLEFINE ITALIA S.P.A. (IT) 2002-12-05 US disclosed
EP-1165633-A1 COMPONENTS AND CATALYSTS FOR THE POLYMERIZATION OF OLEFINS Basell Technology Company B.V. (NL) 2002-01-02 EP disclosed
WO-2001057099-A1 COMPONENTS AND CATALYSTS FOR THE POLYMERIZATION OF OLEFINS BASELL TECHNOLOGY COMPANY B.V. (NL) 2001-08-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020183575-A1 Components and catalysts for the polymerization of olefins SCO2, ECI1, MT-CO2 ZDHHC7 225/4885BIRC2 2974/4885CPB2 1798/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.